Evotec SE
EVONasdaqCIK 1412558HealthcareFiscal year ends Dec 31
Revenue is not reported in this company’s XBRL financial statements.
Latest quarter: not reported
Last eight quarters
Full statements| Line item | Unit | Shape over the periods |
|---|---|---|
| Revenue | $ | |
| Gross margin | % | |
| Operating margin | % | |
| Net margin | % | |
| Diluted EPS | $ per share | |
| Free cash flow | $ |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Last five fiscal years
| Line item | Unit | FY2020-12-31 | FY20212021-12-31 | FY20222022-12-31 | FY20232023-12-31 | FY20242024-12-31 | Shape over the periods |
|---|---|---|---|---|---|---|---|
| Revenue | $m | 501Revenue, period not labelled, twelve months to 2020-12-31EUR 500.9m. XBRL concept ifrs-full:Revenue. 20-F filed 2023-05-12, accession 0001104659-23-059900.Report this figure | 618Revenue, FY2021, twelve months to 2021-12-31EUR 618.0m. XBRL concept ifrs-full:Revenue. 20-F filed 2024-08-14, accession 0001104659-24-089121.Report this figure | 751Revenue, FY2022, twelve months to 2022-12-31EUR 751.4m. XBRL concept ifrs-full:Revenue. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | 781Revenue, FY2023, twelve months to 2023-12-31EUR 781.4m. XBRL concept ifrs-full:Revenue. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | 797Revenue, FY2024, twelve months to 2024-12-31EUR 797.0m. XBRL concept ifrs-full:Revenue. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | |
| Gross margin | % | 25.1%Gross margin, period not labelled, twelve months to 2020-12-31. gross profit / revenueGross profit: EUR 125.7m. XBRL concept ifrs-full:GrossProfit. 20-F filed 2023-05-12, accession 0001104659-23-059900.Revenue: EUR 500.9m. XBRL concept ifrs-full:Revenue. 20-F filed 2023-05-12, accession 0001104659-23-059900.Report this figure | 24.5%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: EUR 151.5m. XBRL concept ifrs-full:GrossProfit. 20-F filed 2024-08-14, accession 0001104659-24-089121.Revenue: EUR 618.0m. XBRL concept ifrs-full:Revenue. 20-F filed 2024-08-14, accession 0001104659-24-089121.Report this figure | 23.2%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: EUR 174.1m. XBRL concept ifrs-full:GrossProfit. 20-F filed 2025-04-17, accession 0001104659-25-035638.Revenue: EUR 751.4m. XBRL concept ifrs-full:Revenue. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | 22.4%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: EUR 175.1m. XBRL concept ifrs-full:GrossProfit. 20-F filed 2025-04-17, accession 0001104659-25-035638.Revenue: EUR 781.4m. XBRL concept ifrs-full:Revenue. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | 14.4%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: EUR 114.9m. XBRL concept ifrs-full:GrossProfit. 20-F filed 2025-04-17, accession 0001104659-25-035638.Revenue: EUR 797.0m. XBRL concept ifrs-full:Revenue. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | |
| Operating margin | % | 9.7%Operating margin, period not labelled, twelve months to 2020-12-31. operating income / revenueOperating income: EUR 48.6m. XBRL concept ifrs-full:ProfitLossFromOperatingActivities. 20-F filed 2023-05-12, accession 0001104659-23-059900.Revenue: EUR 500.9m. XBRL concept ifrs-full:Revenue. 20-F filed 2023-05-12, accession 0001104659-23-059900.Report this figure | 6.6%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: EUR 41.0m. XBRL concept ifrs-full:ProfitLossFromOperatingActivities. 20-F filed 2024-08-14, accession 0001104659-24-089121.Revenue: EUR 618.0m. XBRL concept ifrs-full:Revenue. 20-F filed 2024-08-14, accession 0001104659-24-089121.Report this figure | 2.8%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: EUR 20.9m. XBRL concept ifrs-full:ProfitLossFromOperatingActivities. 20-F filed 2025-04-17, accession 0001104659-25-035638.Revenue: EUR 751.4m. XBRL concept ifrs-full:Revenue. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | (6.1%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −EUR 47.5m. XBRL concept ifrs-full:ProfitLossFromOperatingActivities. 20-F filed 2025-04-17, accession 0001104659-25-035638.Revenue: EUR 781.4m. XBRL concept ifrs-full:Revenue. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | (17.9%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −EUR 142.5m. XBRL concept ifrs-full:ProfitLossFromOperatingActivities. 20-F filed 2025-04-17, accession 0001104659-25-035638.Revenue: EUR 797.0m. XBRL concept ifrs-full:Revenue. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | |
| Net margin | % | 1.3%Net margin, period not labelled, twelve months to 2020-12-31. net income / revenueNet income: EUR 6.3m. XBRL concept ifrs-full:ProfitLossAttributableToOwnersOfParent. 20-F filed 2023-05-12, accession 0001104659-23-059900.Revenue: EUR 500.9m. XBRL concept ifrs-full:Revenue. 20-F filed 2023-05-12, accession 0001104659-23-059900.Report this figure | 34.9%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: EUR 215.5m. XBRL concept ifrs-full:ProfitLossAttributableToOwnersOfParent. 20-F filed 2023-05-12, accession 0001104659-23-059900.Revenue: EUR 618.0m. XBRL concept ifrs-full:Revenue. 20-F filed 2024-08-14, accession 0001104659-24-089121.Report this figure | (23.4%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −EUR 175.7m. XBRL concept ifrs-full:ProfitLossAttributableToOwnersOfParent. 20-F filed 2023-05-12, accession 0001104659-23-059900.Revenue: EUR 751.4m. XBRL concept ifrs-full:Revenue. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | (10.7%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −EUR 83.9m. XBRL concept ifrs-full:ProfitLoss. 20-F filed 2025-04-17, accession 0001104659-25-035638.Revenue: EUR 781.4m. XBRL concept ifrs-full:Revenue. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | (24.6%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −EUR 196.1m. XBRL concept ifrs-full:ProfitLoss. 20-F filed 2025-04-17, accession 0001104659-25-035638.Revenue: EUR 797.0m. XBRL concept ifrs-full:Revenue. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | |
| Diluted EPS | $ per share | 0.04Diluted EPS, period not labelled, twelve months to 2020-12-31EUR 0.04 per share. XBRL concept ifrs-full:DilutedEarningsLossPerShare. 20-F filed 2023-05-12, accession 0001104659-23-059900.Report this figure | 1.30Diluted EPS, FY2021, twelve months to 2021-12-31EUR 1.30 per share. XBRL concept ifrs-full:DilutedEarningsLossPerShare. 20-F filed 2024-08-14, accession 0001104659-24-089121.Report this figure | (0.99)Diluted EPS, FY2022, twelve months to 2022-12-31−EUR 0.99 per share. XBRL concept ifrs-full:DilutedEarningsLossPerShare. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | (0.47)Diluted EPS, FY2023, twelve months to 2023-12-31−EUR 0.47 per share. XBRL concept ifrs-full:DilutedEarningsLossPerShare. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | (1.11)Diluted EPS, FY2024, twelve months to 2024-12-31−EUR 1.11 per share. XBRL concept ifrs-full:DilutedEarningsLossPerShare. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | |
| Free cash flow | $m | (54.4)Free cash flow, period not labelled, twelve months to 2020-12-31. operating cash flow − capital expenditureOperating cash flow: EUR 44.7m. XBRL concept ifrs-full:CashFlowsFromUsedInOperatingActivities. 20-F filed 2023-05-12, accession 0001104659-23-059900.Capital expenditure: EUR 99.1m. XBRL concept ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. 20-F filed 2023-05-12, accession 0001104659-23-059900.Report this figure | 7.7Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: EUR 126.6m. XBRL concept ifrs-full:CashFlowsFromUsedInOperatingActivities. 20-F filed 2024-08-14, accession 0001104659-24-089121.Capital expenditure: EUR 118.9m. XBRL concept ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. 20-F filed 2024-08-14, accession 0001104659-24-089121.Report this figure | 24.5Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: EUR 205.8m. XBRL concept ifrs-full:CashFlowsFromUsedInOperatingActivities. 20-F filed 2025-04-17, accession 0001104659-25-035638.Capital expenditure: EUR 181.4m. XBRL concept ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | (177)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: EUR 36.4m. XBRL concept ifrs-full:CashFlowsFromUsedInOperatingActivities. 20-F filed 2025-04-17, accession 0001104659-25-035638.Capital expenditure: EUR 213.3m. XBRL concept ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure | (99.2)Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: EUR 18.2m. XBRL concept ifrs-full:CashFlowsFromUsedInOperatingActivities. 20-F filed 2025-04-17, accession 0001104659-25-035638.Capital expenditure: EUR 117.5m. XBRL concept ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Insider purchases and sales
All insider transactionsThe last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
No open-market purchases or sales by insiders are in coverage for this company.
Funds that report holding it
All fundsFrom each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|
| DCF Advisers, LLC | 2026-06-30 | $3.0m | 1,079,024 | Added+13,750 | |
| WCM INVESTMENT MANAGEMENT, LLC | 2026-06-30 | $1.9m | 671,884 | Added+44,624 | |
| ABC ARBITRAGE SA | 2026-06-30 | $1.0m | 371,936 | Reduced−137,114 | |
| Optiver Holding B.V. | 2026-06-30 | $902.0k | 322,153 | Added+38,577 | |
| MORGAN STANLEY | 2026-06-30 | $576.1k | 205,763 | Reduced−53,981 | |
| LPL Financial LLC | 2026-06-30 | $464.9k | 166,045 | Added+43,699 | |
| ENVESTNET ASSET MANAGEMENT INC | 2026-06-30 | $390.9k | 139,596 | Added+20,187 | |
| OLD MISSION CAPITAL LLC | 2026-06-30 | $106.5k | 38,032 | Added+18,690 | |
| Pathstone Holdings, LLC | 2026-06-30 | $100.2k | 35,779 | Added+1,652 | |
| Fore Capital, LLC | 2026-06-30 | $87.8k | 31,355 | Unchanged |
Recent filings
All 149 filingsReports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1512:43 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-15 | 0001104659-26-116003 |
| 2026-10-1421:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-115869 |
| 2026-10-1410:02 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-14 | 0001104659-26-115678 |
| 2026-09-2910:01 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-29 | 0001104659-26-111508 |
| 2026-09-0910:05 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-09 | 0001104659-26-106064 |
| 2026-08-1310:05 ET | 6-K | Report of a foreign private issuerPeriod 2026-08-13 | 0001104659-26-095267 |
| 2026-07-1421:54 ET | 6-K | Report of a foreign private issuerPeriod 2026-07-13 | 0001104659-26-083179 |
| 2026-06-3017:01 ET | 6-K | Report of a foreign private issuerPeriod 2026-06-30 | 0001104659-26-079222 |
| 2026-06-1710:02 ET | 6-K | Report of a foreign private issuerPeriod 2026-06-17 | 0001104659-26-074806 |
| 2026-05-0613:39 ET | 6-K | Report of a foreign private issuerPeriod 2026-05-06 | 0001104659-26-055957 |
Latest annual report
Form 20-F for the fiscal year ended Dec 31, 2025Filed Apr 8, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.
Forecast league
Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league
About the filer
- CIK
- 1412558
- Tickers
- EVO, EVOTF
- Exchange
- Nasdaq
- SIC code
- 2834 Pharmaceutical Preparations
- Sector
- Healthcare
- Fiscal year ends
- Dec 31
- Incorporated in
- 2M
- Filer category
- Large accelerated filer
- Former names
- Evotec AG (to 2021-09-23)
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.